Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study) - Kalff, A; Khong, T; Mithraprabhu, S; Bergin, K; Reynolds, J; Bowen, KM; Thakurta, A; Guzman, R; Wang, M; Couto, S; Ren, Y (Leukemia & lymphoma, 2019)
Jun